Colgate-Palmolive Company (CL) Presents at 23rd annual dbAccess Global Consumer Conference Transcript
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive, a global leader in health and hygiene, today announced the launch of Serving Smiles, a new video-first podcast designed to tackle health misinformation an
CL balances pricing and volume growth as emerging markets and innovation support sales momentum.
Some people aren't trusting this market rally, which continues to move higher. Every portfolio should have some defensive plays in it in case of a market downturn.

My 5 Favorite Dividend Stocks to Buy Right Now

07:50am, Saturday, 23'rd May 2026
Consumer staples companies tend to generate resilient cash flows because their products and services remain in demand across all economic environments. The strength of Dividend Kings and long-term gro
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chief Operating Officer, Americas, Shane Grant and Executive Vice President, M&A and Special Projects, John Faucher will participate in a firesid
CL's innovation strategy is driving market share gains as premium launches, pricing and science-based products support growth across oral care and pet nutrition.
Colgate-Palmolive (NYSE:CL | CL Price Prediction) is exactly the kind of name investors hunt for when the macro picture gets murky.
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of Ollie's Bargain Outlet (OLLI) and Colgate-Palmolive (CL). But which of these two companies is
PG's U.S. Baby Care slump remains a weak spot, but strong global growth and targeted investments suggest it is a fixable issue, not a long-term drag.
Colgate-Palmolive delivered 8% sales growth in Q1 2026, but EPS declined 6%, warranting a conservative hold rating. I see organic growth of just 2.9%, with North America sales falling due to increased
Companies like Procter & Gamble and Colgate-Palmolive have embedded themselves so deeply into daily habits that buying their products stops feeling like a decision at all. Their growth narratives are
Colgate-Palmolive (NYSE:CL | CL Price Prediction) stock picked up a fresh price target raise from JPMorgan on Monday, May 4, with the firm lifting its target to $96 from $95 while maintaining its Over
Colgate-Palmolive remains a Buy, supported by resilient fundamentals, an attractive and still sustainable dividend yield while they hold the Dividend King status, and prudent valuation amid macro and
Organic Sales Growth: Accelerated from the fourth quarter, driven by improved volume performance, particularly in Asia Pacific.Volume and Pricing Growth: Achie
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE